- Home
- LAES vs NPCE Comparison
LAES vs NPCE Comparison
Compare LAES & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAES
- NPCE
- Stock Information
- Founded
- LAES 2022
- NPCE 1997
- Country
- LAES Switzerland
- NPCE United States
- Employees
- LAES N/A
- NPCE N/A
- Industry
- LAES Semiconductors
- NPCE Medical Specialities
- Sector
- LAES Technology
- NPCE Health Care
- Exchange
- LAES Nasdaq
- NPCE Nasdaq
- Market Cap
- LAES 366.0M
- NPCE 292.9M
- IPO Year
- LAES N/A
- NPCE 2021
- Fundamental
- Price
- LAES $3.44
- NPCE $9.80
- Analyst Decision
- LAES Strong Buy
- NPCE Strong Buy
- Analyst Count
- LAES 1
- NPCE 6
- Target Price
- LAES $6.00
- NPCE $16.67
- AVG Volume (30 Days)
- LAES 5.7M
- NPCE 182.2K
- Earning Date
- LAES 09-25-2025
- NPCE 11-11-2025
- Dividend Yield
- LAES N/A
- NPCE N/A
- EPS Growth
- LAES N/A
- NPCE N/A
- EPS
- LAES N/A
- NPCE N/A
- Revenue
- LAES $10,978,000.00
- NPCE $88,570,000.00
- Revenue This Year
- LAES N/A
- NPCE $22.13
- Revenue Next Year
- LAES N/A
- NPCE $6.07
- P/E Ratio
- LAES N/A
- NPCE N/A
- Revenue Growth
- LAES N/A
- NPCE 23.32
- 52 Week Low
- LAES $0.31
- NPCE $5.45
- 52 Week High
- LAES $11.00
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- LAES 69.08
- NPCE 57.80
- Support Level
- LAES $2.49
- NPCE $9.65
- Resistance Level
- LAES $3.54
- NPCE $10.12
- Average True Range (ATR)
- LAES 0.20
- NPCE 0.39
- MACD
- LAES 0.12
- NPCE 0.08
- Stochastic Oscillator
- LAES 90.48
- NPCE 70.51
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.